PortfoliosLab logoPortfoliosLab logo
PANW vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PANW vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Palo Alto Networks, Inc. (PANW) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PANW achieves a 89.28% return, which is significantly higher than NVO's 0.91% return. Over the past 10 years, PANW has outperformed NVO with an annualized return of 32.08%, while NVO has yielded a comparatively lower 8.18% annualized return.


PANW

1D
-2.79%
1M
21.16%
6M
85.79%
YTD
89.28%
1Y
78.09%
3Y*
41.95%
5Y*
39.80%
10Y*
32.08%
ALL TIME*
29.66%

NVO

1D
-1.41%
1M
14.86%
6M
-17.63%
YTD
0.91%
1Y
-19.26%
3Y*
-13.51%
5Y*
4.43%
10Y*
8.18%
ALL TIME*
14.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PANW vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PANW
Palo Alto Networks, Inc.
89.28%1.23%23.41%111.32%-24.81%56.66%53.68%22.78%29.95%15.91%
NVO
Novo Nordisk A/S
0.91%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between PANW and NVO is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Jul 20, 2012

0.24

Fundamentals

Market Cap

PANW:

$237.62B

NVO:

$220.46B

EPS

PANW:

$1.17

NVO:

DKK 27.42

PE Ratio

PANW:

297.34

NVO:

11.83

PEG Ratio

PANW:

0.02

NVO:

0.51

PS Ratio

PANW:

23.63

NVO:

4.40

PB Ratio

PANW:

9.38

NVO:

7.11

Total Revenue (TTM)

PANW:

$10.61B

NVO:

DKK 327.80B

Gross Profit (TTM)

PANW:

$7.63B

NVO:

DKK 268.30B

EBITDA (TTM)

PANW:

$1.33B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PANW vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PANW
PANW Risk / Return Rank: 8585
Overall Rank
PANW Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
PANW Sortino Ratio Rank: 8686
Sortino Ratio Rank
PANW Omega Ratio Rank: 8686
Omega Ratio Rank
PANW Calmar Ratio Rank: 8181
Calmar Ratio Rank
PANW Martin Ratio Rank: 8080
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 3030
Overall Rank
NVO Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 2929
Sortino Ratio Rank
NVO Omega Ratio Rank: 2929
Omega Ratio Rank
NVO Calmar Ratio Rank: 3232
Calmar Ratio Rank
NVO Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PANW vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Palo Alto Networks, Inc. (PANW) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PANWNVODifference
Sharpe ratioReturn per unit of total volatility

+2.27

Sortino ratioReturn per unit of downside risk

+2.62

Omega ratioGain probability vs. loss probability

1.32

0.97

+0.34

Calmar ratioReturn relative to maximum drawdown

2.18

-0.39

+2.57

Martin ratioReturn relative to average drawdown

4.95

-0.61

+5.56

PANW vs. NVO - Sharpe Ratio Comparison

The current PANW Sharpe Ratio is 1.90, which is higher than the NVO Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of PANW and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PANW vs. NVO - Drawdown Comparison

The maximum PANW drawdown since its inception was -47.98%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for PANW and NVO.


Loading charts...

Drawdown Indicators


PANWNVODifference

Max Drawdown

Largest peak-to-trough decline

-47.98%

-74.70%

+26.72%

Max Drawdown (1Y)

Largest decline over 1 year

-36.01%

-49.17%

+13.16%

Max Drawdown (3Y)

Largest decline over 3 years

-36.01%

-74.70%

+38.69%

Max Drawdown (5Y)

Largest decline over 5 years

-36.01%

-74.70%

+38.69%

Max Drawdown (10Y)

Largest decline over 10 years

-47.98%

-74.70%

+26.72%

Current Drawdown

Current decline from peak

-2.79%

-63.95%

+61.16%

Average Drawdown

Average peak-to-trough decline

-14.61%

-17.89%

+3.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.83%

31.75%

-15.92%

Volatility

PANW vs. NVO - Volatility Comparison

Palo Alto Networks, Inc. (PANW) has a higher volatility of 16.86% compared to Novo Nordisk A/S (NVO) at 9.48%. This indicates that PANW's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PANWNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

16.86%

9.48%

+7.38%

Volatility (6M)

Calculated over the trailing 6-month period

35.54%

37.43%

-1.89%

Volatility (1Y)

Calculated over the trailing 1-year period

41.49%

51.79%

-10.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.35%

38.58%

+3.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.89%

32.63%

+6.26%

Dividends

PANW vs. NVO - Dividend Comparison

PANW has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.63%.


PositionTTM20252024202320222021202020192018201720162015
NVO
Novo Nordisk A/S
3.63%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
PANW
Palo Alto Networks, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PANW vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Palo Alto Networks, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
3.00B
96.82B
(PANW) Total Revenue
(NVO) Total Revenue
Please note, different currencies. PANW values in USD, NVO values in DKK

PANW vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Palo Alto Networks, Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

70.0%75.0%80.0%85.0%20222023202420252026
67.6%
86.0%
Portfolio components
PANW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Palo Alto Networks, Inc. reported a gross profit of 2.03B and revenue of 3.00B. Therefore, the gross margin over that period was 67.6%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

PANW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Palo Alto Networks, Inc. reported an operating income of -186.00M and revenue of 3.00B, resulting in an operating margin of -6.2%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

PANW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Palo Alto Networks, Inc. reported a net income of -177.00M and revenue of 3.00B, resulting in a net margin of -5.9%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


PANW and NVO have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PANW has higher volatility (16.86%) compared to NVO (9.48%). In terms of maximum drawdown, PANW dropped -47.98% vs NVO's -74.70%.

PANW currently has the higher Sharpe Ratio (1.90 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PANW and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer